معرفی
Dan Atar is a Professor II at the Medical Clinic (MDK) of the University of Oslo, serving as Research Manager and Editor-in-Chief of Cardiology. Specializing in cardiology, he holds visiting appointments at Johns Hopkins University and has led major clinical trials (e.g., BETAMI, ARTESIA, FOURIER-OLE). His research focuses on myocardial infarction, troponin biomarkers, and cardiovascular pharmacotherapy.
- Education: Specialist in Cardiology/Internal Medicine from Denmark and Switzerland.
- Key Roles: Chair of the FESC Task Force (ESC), ESC Treasurer/Secretary (2018–2020), and leader of international clinical trials.
Research Interests: Prevention of reperfusion injury in heart attacks, atrial fibrillation pharmacology, and cardiovascular drug efficacy. He pioneered the BETAMI trial evaluating beta-blockers post-MI and contributed to global treatment guidelines.
Awards: Recipient of the Heart Research Award from the National Association for Public Health (presented by King Harald V of Norway), Ole Storstein Prize, and Doctor honoris causa from the University of Bucharest. Ranked among the top 25 most cited researchers in Norway (2019).
Grants & Projects: Secured 12 MNOK from the Research Council of Norway (2019), EU Horizon2020 funding for EXHAUSTION (climate and cardiovascular health), and Eurostars grants for WATCH IT and PILLOXA. Active in the Mitocare consortium and the ESC Guidelines Writing Committee.
Labs & Teams: Leads the Clinical Cardiovascular Research Group at UiO and collaborates with institutions like Sydney University and the University of Texas.
